-
1
-
-
67449150231
-
Increasing burden of melanoma in the United States
-
Linos E., Swetter S.M., Cockburn M.G., Colditz G.A., Clarke C.A. Increasing burden of melanoma in the United States. J Invest Dermatol 2009, 129:1666-1674.
-
(2009)
J Invest Dermatol
, vol.129
, pp. 1666-1674
-
-
Linos, E.1
Swetter, S.M.2
Cockburn, M.G.3
Colditz, G.A.4
Clarke, C.A.5
-
2
-
-
79151469677
-
The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision margins
-
Mocellin S., Pasquali S., Nitti D. The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision margins. Ann Surg 2011, 253:238-243.
-
(2011)
Ann Surg
, vol.253
, pp. 238-243
-
-
Mocellin, S.1
Pasquali, S.2
Nitti, D.3
-
3
-
-
75349107047
-
Surgical excision margins for primary cutaneous melanoma
-
CD004835
-
Sladden M.J., Balch C., Barzilai D.A., Berg D., Freiman A., Handiside T., et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009, CD004835.
-
(2009)
Cochrane Database Syst Rev
-
-
Sladden, M.J.1
Balch, C.2
Barzilai, D.A.3
Berg, D.4
Freiman, A.5
Handiside, T.6
-
4
-
-
84872614316
-
Adjuvant interferon alfa in malignant melanoma: an interdisciplinary and multinational expert review
-
Ascierto P.A., Gogas H.J., Grob J.J., Algarra S.M., Mohr P., Hansson J., et al. Adjuvant interferon alfa in malignant melanoma: an interdisciplinary and multinational expert review. Crit Rev Oncol Hematol 2013, 85:149-161.
-
(2013)
Crit Rev Oncol Hematol
, vol.85
, pp. 149-161
-
-
Ascierto, P.A.1
Gogas, H.J.2
Grob, J.J.3
Algarra, S.M.4
Mohr, P.5
Hansson, J.6
-
5
-
-
33749053823
-
Sentinel-node biopsy or nodal observation in melanoma
-
Morton D.L., Thompson J.F., Cochran A.J., Mozzillo N., Elashoff R., Essner R., et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006, 355:1307-1317.
-
(2006)
N Engl J Med
, vol.355
, pp. 1307-1317
-
-
Morton, D.L.1
Thompson, J.F.2
Cochran, A.J.3
Mozzillo, N.4
Elashoff, R.5
Essner, R.6
-
6
-
-
84893730461
-
Final trial report of sentinel-node biopsy versus nodal observation in melanoma
-
Morton D.L., Thompson J.F., Cochran A.J., Mozzillo N., Nieweg O.E., Roses D.F., et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014, 370:599-609.
-
(2014)
N Engl J Med
, vol.370
, pp. 599-609
-
-
Morton, D.L.1
Thompson, J.F.2
Cochran, A.J.3
Mozzillo, N.4
Nieweg, O.E.5
Roses, D.F.6
-
7
-
-
84873670582
-
Call for a balanced view on sentinel node biopsy for melanoma
-
Geh J.L., Healy C., Lacy K., Wain M., Attard N., Calonje E., et al. Call for a balanced view on sentinel node biopsy for melanoma. BMJ 2013, 346:f648.
-
(2013)
BMJ
, vol.346
-
-
Geh, J.L.1
Healy, C.2
Lacy, K.3
Wain, M.4
Attard, N.5
Calonje, E.6
-
8
-
-
70349577393
-
Utility of adjuvant systemic therapy in melanoma
-
Eggermont A.M., Testori A., Marsden J., Hersey P., Quirt I., Petrella T., et al. Utility of adjuvant systemic therapy in melanoma. Ann Oncol 2009, 20(Suppl. 6):vi30-vi34.
-
(2009)
Ann Oncol
, vol.20
, Issue.SUPPL. 6
-
-
Eggermont, A.M.1
Testori, A.2
Marsden, J.3
Hersey, P.4
Quirt, I.5
Petrella, T.6
-
9
-
-
84864368720
-
Adjuvant nodal irradiation in melanoma
-
(author reply e7)
-
Khattak M., Gore M., Larkin J., Strauss D., Thomas M., Hayes A., et al. Adjuvant nodal irradiation in melanoma. Lancet Oncol 2012, 13:326-327. (author reply e7).
-
(2012)
Lancet Oncol
, vol.13
, pp. 326-327
-
-
Khattak, M.1
Gore, M.2
Larkin, J.3
Strauss, D.4
Thomas, M.5
Hayes, A.6
-
11
-
-
79957970164
-
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria
-
van der Ploeg A.P., van Akkooi A.C., Rutkowski P., Nowecki Z.I., Michej W., Mitra A., et al. Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol 2011, 29:2206-2214.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2206-2214
-
-
van der Ploeg, A.P.1
van Akkooi, A.C.2
Rutkowski, P.3
Nowecki, Z.I.4
Michej, W.5
Mitra, A.6
-
12
-
-
77952532215
-
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases
-
Balch C.M., Gershenwald J.E., Soong S.J., Thompson J.F., Ding S., Byrd D.R., et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010, 28:2452-2459.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2452-2459
-
-
Balch, C.M.1
Gershenwald, J.E.2
Soong, S.J.3
Thompson, J.F.4
Ding, S.5
Byrd, D.R.6
-
13
-
-
77149124228
-
Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis
-
Pasquali S., Mocellin S., Campana L.G., Bonandini E., Montesco M.C., Tregnaghi A., et al. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis. Cancer 2010, 116:1201-1209.
-
(2010)
Cancer
, vol.116
, pp. 1201-1209
-
-
Pasquali, S.1
Mocellin, S.2
Campana, L.G.3
Bonandini, E.4
Montesco, M.C.5
Tregnaghi, A.6
-
14
-
-
84891717162
-
Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden
-
Spillane A.J., Pasquali S., Haydu L.E., Thompson J.F. Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden. Ann Surg Oncol 2014, 21:292-299.
-
(2014)
Ann Surg Oncol
, vol.21
, pp. 292-299
-
-
Spillane, A.J.1
Pasquali, S.2
Haydu, L.E.3
Thompson, J.F.4
-
15
-
-
84868205047
-
Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma
-
Morton D.L. Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis 2012, 29:699-706.
-
(2012)
Clin Exp Metastasis
, vol.29
, pp. 699-706
-
-
Morton, D.L.1
-
16
-
-
84876494846
-
Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey
-
Pasquali S., Spillane A.J., de Wilt J.H., McCaffery K., Rossi C.R., Quinn M.J., et al. Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey. Ann Surg Oncol. 2012, 19:4322-4329.
-
(2012)
Ann Surg Oncol.
, vol.19
, pp. 4322-4329
-
-
Pasquali, S.1
Spillane, A.J.2
de Wilt, J.H.3
McCaffery, K.4
Rossi, C.R.5
Quinn, M.J.6
-
17
-
-
79751522951
-
Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial
-
Giuliano A.E., Hunt K.K., Ballman K.V., Beitsch P.D., Whitworth P.W., Blumencranz P.W., et al. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011, 305:569-575.
-
(2011)
JAMA
, vol.305
, pp. 569-575
-
-
Giuliano, A.E.1
Hunt, K.K.2
Ballman, K.V.3
Beitsch, P.D.4
Whitworth, P.W.5
Blumencranz, P.W.6
-
18
-
-
84900421315
-
Sentinel lymph node biopsy for patients with early-stage breast cancer: american Society of Clinical Oncology clinical practice guideline update
-
Lyman G.H., Temin S., Edge S.B., Newman L.A., Turner R.R., Weaver D.L., et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: american Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2014, 32:1365-1383.
-
(2014)
J Clin Oncol
, vol.32
, pp. 1365-1383
-
-
Lyman, G.H.1
Temin, S.2
Edge, S.B.3
Newman, L.A.4
Turner, R.R.5
Weaver, D.L.6
-
19
-
-
84891627916
-
The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients
-
van der Ploeg A.P., van Akkooi A.C., Haydu L.E., Scolyer R.A., Murali R., Verhoef C., et al. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients. Eur J Cancer 2014, 50:111-120.
-
(2014)
Eur J Cancer
, vol.50
, pp. 111-120
-
-
van der Ploeg, A.P.1
van Akkooi, A.C.2
Haydu, L.E.3
Scolyer, R.A.4
Murali, R.5
Verhoef, C.6
-
20
-
-
4344630988
-
The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement
-
Dewar D.J., Newell B., Green M.A., Topping A.P., Powell B.W., Cook M.G. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004, 22:3345-3349.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3345-3349
-
-
Dewar, D.J.1
Newell, B.2
Green, M.A.3
Topping, A.P.4
Powell, B.W.5
Cook, M.G.6
-
21
-
-
0035371058
-
A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma
-
Starz H., Balda B.R., Kramer K.U., Buchels H., Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001, 91:2110-2121.
-
(2001)
Cancer
, vol.91
, pp. 2110-2121
-
-
Starz, H.1
Balda, B.R.2
Kramer, K.U.3
Buchels, H.4
Wang, H.5
-
22
-
-
52049107850
-
Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma
-
Gershenwald J.E., Andtbacka R.H., Prieto V.G., Johnson M.M., Diwan A.H., Lee J.E., et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 2008, 26:4296-4303.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4296-4303
-
-
Gershenwald, J.E.1
Andtbacka, R.H.2
Prieto, V.G.3
Johnson, M.M.4
Diwan, A.H.5
Lee, J.E.6
-
23
-
-
0034979375
-
Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment
-
Cochran A.J., Morton D.L., Stern S., Lana A.M., Essner R., Wen D.R. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 2001, 14:604-608.
-
(2001)
Mod Pathol
, vol.14
, pp. 604-608
-
-
Cochran, A.J.1
Morton, D.L.2
Stern, S.3
Lana, A.M.4
Essner, R.5
Wen, D.R.6
-
24
-
-
78649456985
-
Non-sentinel node risk score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes
-
Murali R., Desilva C., Thompson J.F., Scolyer R.A. Non-sentinel node risk score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes. J Clin Oncol 2010, 28:4441-4449.
-
(2010)
J Clin Oncol
, vol.28
, pp. 4441-4449
-
-
Murali, R.1
Desilva, C.2
Thompson, J.F.3
Scolyer, R.A.4
-
25
-
-
84899761053
-
Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study
-
Pasquali S., Mocellin S., Mozzillo N., Maurichi A., Quaglino P., Borgognoni L., et al. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study. J Clin Oncol 2014.
-
(2014)
J Clin Oncol
-
-
Pasquali, S.1
Mocellin, S.2
Mozzillo, N.3
Maurichi, A.4
Quaglino, P.5
Borgognoni, L.6
-
26
-
-
84873735877
-
Completion lymph node dissection after a positive sentinel node: no longer a must?
-
van der Ploeg A.P., van Akkooi A.C., Verhoef C., Eggermont A.M. Completion lymph node dissection after a positive sentinel node: no longer a must?. Curr Opin Oncol 2013, 25:152-159.
-
(2013)
Curr Opin Oncol
, vol.25
, pp. 152-159
-
-
van der Ploeg, A.P.1
van Akkooi, A.C.2
Verhoef, C.3
Eggermont, A.M.4
-
27
-
-
84865112386
-
Australian Cancer Network Melanoma Guidelines Revision Working Party
-
Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group, Wellington
-
Australian Cancer Network Melanoma Guidelines Revision Working Party Clinical practice guidelines for the management of melanoma in Australia and New Zealand 2008, Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group, Wellington.
-
(2008)
Clinical practice guidelines for the management of melanoma in Australia and New Zealand
-
-
-
28
-
-
85081463830
-
-
National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Melanoma. [accessed on 1st June 2014].
-
National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Melanoma. www.nccn.org 2014 [accessed on 1st June 2014].
-
(2014)
-
-
-
29
-
-
84893933188
-
Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma
-
Gyorki D.E., Boyle J.O., Ganly I., Morris L., Shaha A.R., Singh B., et al. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma. Eur J Surg Oncol 2014, 40:305-310.
-
(2014)
Eur J Surg Oncol
, vol.40
, pp. 305-310
-
-
Gyorki, D.E.1
Boyle, J.O.2
Ganly, I.3
Morris, L.4
Shaha, A.R.5
Singh, B.6
-
30
-
-
84860422478
-
Is a level III dissection necessary for a positive sentinel lymph node in melanoma?
-
Namm J.P., Chang A.E., Cimmino V.M., Rees R.S., Johnson T.M., Sabel M.S. Is a level III dissection necessary for a positive sentinel lymph node in melanoma?. J Surg Oncol 2012, 105:225-228.
-
(2012)
J Surg Oncol
, vol.105
, pp. 225-228
-
-
Namm, J.P.1
Chang, A.E.2
Cimmino, V.M.3
Rees, R.S.4
Johnson, T.M.5
Sabel, M.S.6
-
31
-
-
84878247233
-
How often do level III nodes bear melanoma metastases and does it affect patient outcomes?
-
Nessim C., Law C., McConnell Y., Shachar S., McKinnon G., Wright F. How often do level III nodes bear melanoma metastases and does it affect patient outcomes?. Ann Surg Oncol 2013, 20:2056-2064.
-
(2013)
Ann Surg Oncol
, vol.20
, pp. 2056-2064
-
-
Nessim, C.1
Law, C.2
McConnell, Y.3
Shachar, S.4
McKinnon, G.5
Wright, F.6
-
32
-
-
80052757930
-
Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population
-
Spillane A.J., Haydu L., McMillan W., Stretch J.R., Thompson J.F. Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population. Ann Surg Oncol. 2011, 18:2521-2528.
-
(2011)
Ann Surg Oncol.
, vol.18
, pp. 2521-2528
-
-
Spillane, A.J.1
Haydu, L.2
McMillan, W.3
Stretch, J.R.4
Thompson, J.F.5
-
33
-
-
63449105286
-
Proposed quality standards for regional lymph node dissections in patients with1 melanoma
-
Spillane A.J., Cheung B.L., Stretch J.R., Scolyer R.A., Shannon K.F., Quinn M.J., et al. Proposed quality standards for regional lymph node dissections in patients with1 melanoma. Ann Surg 2009, 249:473-480.
-
(2009)
Ann Surg
, vol.249
, pp. 473-480
-
-
Spillane, A.J.1
Cheung, B.L.2
Stretch, J.R.3
Scolyer, R.A.4
Shannon, K.F.5
Quinn, M.J.6
-
34
-
-
85081463373
-
-
ANZMTG 01.12 Inguinal or Ilio-inguinal Lymphadenectomy for patients with metastatic melanoma to groin lymph nodes and no evidence of pelvic disease on PET/CT Scan - A randomised phase III trial (EAGLE FM)
-
ANZMTG 01.12 Inguinal or Ilio-inguinal Lymphadenectomy for patients with metastatic melanoma to groin lymph nodes and no evidence of pelvic disease on PET/CT Scan - A randomised phase III trial (EAGLE FM) 2013.
-
(2013)
-
-
-
35
-
-
80052778929
-
Lymph node evaluation in colon cancer: assessing the link between quality indicators and quality
-
Wong S.L. Lymph node evaluation in colon cancer: assessing the link between quality indicators and quality. Jama 2011, 306:1139-1141.
-
(2011)
Jama
, vol.306
, pp. 1139-1141
-
-
Wong, S.L.1
-
36
-
-
84904675632
-
The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis
-
Rossi C.R., Mozzillo N., Maurichi A., Pasquali S., Quaglino P., Borgognoni Lorenzo, et al. The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis. Ann Oncol 2014, 25:240-246.
-
(2014)
Ann Oncol
, vol.25
, pp. 240-246
-
-
Rossi, C.R.1
Mozzillo, N.2
Maurichi, A.3
Pasquali, S.4
Quaglino, P.5
Borgognoni, L.6
-
37
-
-
84891703353
-
Interferon alpha for the adjuvant treatment of cutaneous melanoma
-
CD008955
-
Mocellin S., Lens M.B., Pasquali S., Pilati P., Chiarion Sileni V. Interferon alpha for the adjuvant treatment of cutaneous melanoma. Cochrane Database Syst Rev 2013, 6. CD008955.
-
(2013)
Cochrane Database Syst Rev
, vol.6
-
-
Mocellin, S.1
Lens, M.B.2
Pasquali, S.3
Pilati, P.4
Chiarion Sileni, V.5
-
38
-
-
84897018318
-
Phase II pilot study of intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence
-
Payne M.J., Argyropoulou K., Lorigan P., McAleer J.J., Farrugia D., Davidson N., et al. Phase II pilot study of intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence. J Clin Oncol 2014, 32:185-190.
-
(2014)
J Clin Oncol
, vol.32
, pp. 185-190
-
-
Payne, M.J.1
Argyropoulou, K.2
Lorigan, P.3
McAleer, J.J.4
Farrugia, D.5
Davidson, N.6
-
39
-
-
33748068119
-
The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis
-
Mocellin S., Hoon D., Ambrosi A., Nitti D., Rossi C.R. The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res 2006, 12:4605-4613.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 4605-4613
-
-
Mocellin, S.1
Hoon, D.2
Ambrosi, A.3
Nitti, D.4
Rossi, C.R.5
-
40
-
-
70450240907
-
Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study)
-
Fusi A., Collette S., Busse A., Suciu S., Rietz A., Santinami M., et al. Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study). Eur J Cancer 2009, 45:3189-3197.
-
(2009)
Eur J Cancer
, vol.45
, pp. 3189-3197
-
-
Fusi, A.1
Collette, S.2
Busse, A.3
Suciu, S.4
Rietz, A.5
Santinami, M.6
-
41
-
-
84655168007
-
Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991
-
Eggermont A.M., Suciu S., Testori A., Kruit W.H., Marsden J., Punt C.J., et al. Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur J Cancer 2012, 48:218-225.
-
(2012)
Eur J Cancer
, vol.48
, pp. 218-225
-
-
Eggermont, A.M.1
Suciu, S.2
Testori, A.3
Kruit, W.H.4
Marsden, J.5
Punt, C.J.6
-
42
-
-
84869212118
-
Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma
-
Eggermont A.M., Suciu S., Testori A., Santinami M., Kruit W.H., Marsden J., et al. Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. J Clin Oncol 2012, 30:3810-3818.
-
(2012)
J Clin Oncol
, vol.30
, pp. 3810-3818
-
-
Eggermont, A.M.1
Suciu, S.2
Testori, A.3
Santinami, M.4
Kruit, W.H.5
Marsden, J.6
-
43
-
-
77956196304
-
Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma
-
discussion 5-6
-
McMasters K.M., Edwards M.J., Ross M.I., Reintgen D.S., Martin R.C., Urist M.M., et al. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg 2010, 252:460-465. discussion 5-6.
-
(2010)
Ann Surg
, vol.252
, pp. 460-465
-
-
McMasters, K.M.1
Edwards, M.J.2
Ross, M.I.3
Reintgen, D.S.4
Martin, R.C.5
Urist, M.M.6
-
44
-
-
84867313947
-
IFN-alpha in the treatment of melanoma
-
Tarhini A.A., Gogas H., Kirkwood J.M. IFN-alpha in the treatment of melanoma. J Immunol 2012, 189:3789-3793.
-
(2012)
J Immunol
, vol.189
, pp. 3789-3793
-
-
Tarhini, A.A.1
Gogas, H.2
Kirkwood, J.M.3
-
45
-
-
84863393623
-
Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma
-
Wilmott J.S., Long G.V., Howle J.R., Haydu L.E., Sharma R.N., Thompson J.F., et al. Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma. Clin Cancer Res 2012, 18:1386-1394.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 1386-1394
-
-
Wilmott, J.S.1
Long, G.V.2
Howle, J.R.3
Haydu, L.E.4
Sharma, R.N.5
Thompson, J.F.6
-
47
-
-
84864052441
-
Management of immune-related adverse events and kinetics of response with ipilimumab
-
Weber J.S., Kahler K.C., Hauschild A. Management of immune-related adverse events and kinetics of response with ipilimumab. J Clin Oncol 2012, 30:2691-2697.
-
(2012)
J Clin Oncol
, vol.30
, pp. 2691-2697
-
-
Weber, J.S.1
Kahler, K.C.2
Hauschild, A.3
-
48
-
-
84861574744
-
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
-
Burmeister B.H., Henderson M.A., Ainslie J., Fisher R., Di Iulio J., Smithers B.M., et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol 2012, 13:589-597.
-
(2012)
Lancet Oncol
, vol.13
, pp. 589-597
-
-
Burmeister, B.H.1
Henderson, M.A.2
Ainslie, J.3
Fisher, R.4
Di Iulio, J.5
Smithers, B.M.6
-
49
-
-
79952453763
-
Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032
-
Sambade M.J., Peters E.C., Thomas N.E., Kaufmann W.K., Kimple R.J., Shields J.M. Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032. Radiother Oncol 2011, 98:394-399.
-
(2011)
Radiother Oncol
, vol.98
, pp. 394-399
-
-
Sambade, M.J.1
Peters, E.C.2
Thomas, N.E.3
Kaufmann, W.K.4
Kimple, R.J.5
Shields, J.M.6
-
50
-
-
84857815877
-
Immunologic correlates of the abscopal effect in a patient with melanoma
-
Postow M.A., Callahan M.K., Barker C.A., Yamada Y., Yuan J., Kitano S., et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 2012, 366:925-931.
-
(2012)
N Engl J Med
, vol.366
, pp. 925-931
-
-
Postow, M.A.1
Callahan, M.K.2
Barker, C.A.3
Yamada, Y.4
Yuan, J.5
Kitano, S.6
-
51
-
-
80052016114
-
Neoadjuvant therapy for high-risk bulky regional melanoma
-
Tarhini A.A., Pahuja S., Kirkwood J.M. Neoadjuvant therapy for high-risk bulky regional melanoma. J Surg Oncol 2011, 104:386-390.
-
(2011)
J Surg Oncol
, vol.104
, pp. 386-390
-
-
Tarhini, A.A.1
Pahuja, S.2
Kirkwood, J.M.3
-
52
-
-
73949134034
-
Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma
-
Sanki A., Uren R.F., Moncrieff M., Tran K.L., Scolyer R.A., Lin H.Y., et al. Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. J Clin Oncol 2009, 27:5614-5619.
-
(2009)
J Clin Oncol
, vol.27
, pp. 5614-5619
-
-
Sanki, A.1
Uren, R.F.2
Moncrieff, M.3
Tran, K.L.4
Scolyer, R.A.5
Lin, H.Y.6
-
53
-
-
77149167615
-
Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?
-
Voit C.A., van Akkooi A.C., Schafer-Hesterberg G., Schoengen A., Schmitz P.I., Sterry W., et al. Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?. J Clin Oncol 2009, 27:4994-5000.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4994-5000
-
-
Voit, C.A.1
van Akkooi, A.C.2
Schafer-Hesterberg, G.3
Schoengen, A.4
Schmitz, P.I.5
Sterry, W.6
-
54
-
-
84881478947
-
Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup
-
Niebling M.G., Bastiaannet E., Hoekstra O.S., Bonenkamp J.J., Koelemij R., Hoekstra H.J. Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup. Ann Surg Oncol 2013, 20:3098-3105.
-
(2013)
Ann Surg Oncol
, vol.20
, pp. 3098-3105
-
-
Niebling, M.G.1
Bastiaannet, E.2
Hoekstra, O.S.3
Bonenkamp, J.J.4
Koelemij, R.5
Hoekstra, H.J.6
-
55
-
-
84863403429
-
Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma
-
Bastiaannet E., Uyl-de Groot C.A., Brouwers A.H., van der Jagt E.J., Hoekstra O.S., Oyen W., et al. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Ann Surg 2012, 255:771-776.
-
(2012)
Ann Surg
, vol.255
, pp. 771-776
-
-
Bastiaannet, E.1
Uyl-de Groot, C.A.2
Brouwers, A.H.3
van der Jagt, E.J.4
Hoekstra, O.S.5
Oyen, W.6
-
56
-
-
84896987510
-
Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma
-
Baker J.J., Meyers M.O., Frank J., Amos K.D., Stitzenberg K.B., Ollila D.W. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma. Am J Surg 2014, 207:549-554.
-
(2014)
Am J Surg
, vol.207
, pp. 549-554
-
-
Baker, J.J.1
Meyers, M.O.2
Frank, J.3
Amos, K.D.4
Stitzenberg, K.B.5
Ollila, D.W.6
-
57
-
-
74949143594
-
Final version of 2009 AJCC melanoma staging and classification
-
Balch C.M., Gershenwald J.E., Soong S.J., Thompson J.F., Atkins M.B., Byrd D.R., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199-6206.
-
(2009)
J Clin Oncol
, vol.27
, pp. 6199-6206
-
-
Balch, C.M.1
Gershenwald, J.E.2
Soong, S.J.3
Thompson, J.F.4
Atkins, M.B.5
Byrd, D.R.6
-
58
-
-
45849107633
-
Pathologic examination of sentinel lymph nodes from melanoma patients
-
Scolyer R.A., Murali R., McCarthy S.W., Thompson J.F. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol 2008, 25:100-111.
-
(2008)
Semin Diagn Pathol
, vol.25
, pp. 100-111
-
-
Scolyer, R.A.1
Murali, R.2
McCarthy, S.W.3
Thompson, J.F.4
-
59
-
-
84856230673
-
Treatment influencing down-staging in EORTC melanoma group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study
-
Riber-Hansen R., Hastrup N., Clemmensen O., Behrendt N., Klausen S., Ramsing M., et al. Treatment influencing down-staging in EORTC melanoma group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study. Eur J Cancer 2012, 48:347-352.
-
(2012)
Eur J Cancer
, vol.48
, pp. 347-352
-
-
Riber-Hansen, R.1
Hastrup, N.2
Clemmensen, O.3
Behrendt, N.4
Klausen, S.5
Ramsing, M.6
-
60
-
-
70350516030
-
Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma
-
Murali R., Cochran A.J., Cook M.G., Hillman J.D., Karim R.Z., Moncrieff M., et al. Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer 2009, 115:5026-5037.
-
(2009)
Cancer
, vol.115
, pp. 5026-5037
-
-
Murali, R.1
Cochran, A.J.2
Cook, M.G.3
Hillman, J.D.4
Karim, R.Z.5
Moncrieff, M.6
-
61
-
-
84862492507
-
Sentinel lymph nodes containing very small (<0.1mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative
-
Murali R., DeSilva C., McCarthy S.W., Thompson J.F., Scolyer R.A. Sentinel lymph nodes containing very small (<0.1mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative. Ann Surg Oncol 2012, 19:1089-1099.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 1089-1099
-
-
Murali, R.1
DeSilva, C.2
McCarthy, S.W.3
Thompson, J.F.4
Scolyer, R.A.5
-
62
-
-
77954953195
-
Sentinel node positive melanoma patients: prediction and prognostic significance of nonsentinel node metastases and development of a survival tree model
-
Wiener M., Acland K.M., Shaw H.M., Soong S.J., Lin H.Y., Chen D.T., et al. Sentinel node positive melanoma patients: prediction and prognostic significance of nonsentinel node metastases and development of a survival tree model. Ann Surg Oncol 2010, 17:1995-2005.
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 1995-2005
-
-
Wiener, M.1
Acland, K.M.2
Shaw, H.M.3
Soong, S.J.4
Lin, H.Y.5
Chen, D.T.6
-
63
-
-
84875230687
-
Diversity of stage III melanoma in the era of sentinel lymph node biopsy
-
Egger M.E., Callender G.G., McMasters K.M., Ross M.I., Martin R.C., Edwards M.J., et al. Diversity of stage III melanoma in the era of sentinel lymph node biopsy. Ann Surg Oncol 2013, 20:956-963.
-
(2013)
Ann Surg Oncol
, vol.20
, pp. 956-963
-
-
Egger, M.E.1
Callender, G.G.2
McMasters, K.M.3
Ross, M.I.4
Martin, R.C.5
Edwards, M.J.6
-
64
-
-
84892368130
-
Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma
-
Grotz T.E., Huebner M., Pockaj B.A., Perkins S., Jakub J.W. Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma. Ann Surg Oncol. 2013, 20:4370-4377.
-
(2013)
Ann Surg Oncol.
, vol.20
, pp. 4370-4377
-
-
Grotz, T.E.1
Huebner, M.2
Pockaj, B.A.3
Perkins, S.4
Jakub, J.W.5
-
65
-
-
84885577769
-
Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome
-
Hughes M.C., Wright A., Barbour A., Thomas J., Smithers B.M., Green A.C., et al. Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome. Int J Cancer 2013, 133:3000-3007.
-
(2013)
Int J Cancer
, vol.133
, pp. 3000-3007
-
-
Hughes, M.C.1
Wright, A.2
Barbour, A.3
Thomas, J.4
Smithers, B.M.5
Green, A.C.6
-
66
-
-
78751629245
-
Lymph node ratio provides prognostic information in addition to american joint committee on cancer N stage in patients with melanoma, even if quality of surgery is standardized
-
Spillane A.J., Cheung B.L., Winstanley J., Thompson J.F. Lymph node ratio provides prognostic information in addition to american joint committee on cancer N stage in patients with melanoma, even if quality of surgery is standardized. Ann Surg 2011, 253:109-115.
-
(2011)
Ann Surg
, vol.253
, pp. 109-115
-
-
Spillane, A.J.1
Cheung, B.L.2
Winstanley, J.3
Thompson, J.F.4
-
67
-
-
36148966515
-
Hospital lymph node examination rates and survival after resection for colon cancer
-
Wong S.L., Ji H., Hollenbeck B.K., Morris A.M., Baser O., Birkmeyer J.D. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 2007, 298:2149-2154.
-
(2007)
JAMA
, vol.298
, pp. 2149-2154
-
-
Wong, S.L.1
Ji, H.2
Hollenbeck, B.K.3
Morris, A.M.4
Baser, O.5
Birkmeyer, J.D.6
-
68
-
-
33748076467
-
Tumour-induced immune modulation of sentinel lymph nodes
-
Cochran A.J., Huang R.R., Lee J., Itakura E., Leong S.P., Essner R. Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol 2006, 6:659-670.
-
(2006)
Nat Rev Immunol
, vol.6
, pp. 659-670
-
-
Cochran, A.J.1
Huang, R.R.2
Lee, J.3
Itakura, E.4
Leong, S.P.5
Essner, R.6
-
69
-
-
80052034187
-
Prognostic molecular biomarkers for cutaneous malignant melanoma
-
Tanaka R., Koyanagi K., Narita N., Kuo C., Hoon D.S. Prognostic molecular biomarkers for cutaneous malignant melanoma. J Surg Oncol 2011, 104:438-446.
-
(2011)
J Surg Oncol
, vol.104
, pp. 438-446
-
-
Tanaka, R.1
Koyanagi, K.2
Narita, N.3
Kuo, C.4
Hoon, D.S.5
-
70
-
-
78751622090
-
Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients
-
Nicholl M.B., Elashoff D., Takeuchi H., Morton D.L., Hoon D.S. Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients. Ann Surg 2011, 253:116-122.
-
(2011)
Ann Surg
, vol.253
, pp. 116-122
-
-
Nicholl, M.B.1
Elashoff, D.2
Takeuchi, H.3
Morton, D.L.4
Hoon, D.S.5
-
71
-
-
34248212172
-
Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis
-
Mocellin S., Hoon D.S., Pilati P., Rossi C.R., Nitti D. Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. J Clin Oncol 2007, 25:1588-1595.
-
(2007)
J Clin Oncol
, vol.25
, pp. 1588-1595
-
-
Mocellin, S.1
Hoon, D.S.2
Pilati, P.3
Rossi, C.R.4
Nitti, D.5
-
72
-
-
33749054227
-
Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival
-
Cascinelli N., Bombardieri E., Bufalino R., Camerini T., Carbone A., Clemente C., et al. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. J Clin Oncol 2006, 24:4464-4471.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4464-4471
-
-
Cascinelli, N.1
Bombardieri, E.2
Bufalino, R.3
Camerini, T.4
Carbone, A.5
Clemente, C.6
-
73
-
-
84876794607
-
Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes
-
Pasquali S., van der Ploeg A.P., Mocellin S., Stretch J.R., Thompson J.F., Scolyer R.A. Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes. Pigment Cell Melanoma Res 2013, 26:326-337.
-
(2013)
Pigment Cell Melanoma Res
, vol.26
, pp. 326-337
-
-
Pasquali, S.1
van der Ploeg, A.P.2
Mocellin, S.3
Stretch, J.R.4
Thompson, J.F.5
Scolyer, R.A.6
-
74
-
-
84864059882
-
Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma
-
Azimi F., Scolyer R.A., Rumcheva P., Moncrieff M., Murali R., McCarthy S.W., et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol 2012, 30:2678-2683.
-
(2012)
J Clin Oncol
, vol.30
, pp. 2678-2683
-
-
Azimi, F.1
Scolyer, R.A.2
Rumcheva, P.3
Moncrieff, M.4
Murali, R.5
McCarthy, S.W.6
-
75
-
-
84859433376
-
Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma
-
Storr S.J., Safuan S., Mitra A., Elliott F., Walker C., Vasko M.J., et al. Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma. Mod Pathol 2012, 25:493-504.
-
(2012)
Mod Pathol
, vol.25
, pp. 493-504
-
-
Storr, S.J.1
Safuan, S.2
Mitra, A.3
Elliott, F.4
Walker, C.5
Vasko, M.J.6
-
77
-
-
0038243830
-
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival
-
Dadras S.S., Paul T., Bertoncini J., Brown L.F., Muzikansky A., Jackson D.G., et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003, 162:1951-1960.
-
(2003)
Am J Pathol
, vol.162
, pp. 1951-1960
-
-
Dadras, S.S.1
Paul, T.2
Bertoncini, J.3
Brown, L.F.4
Muzikansky, A.5
Jackson, D.G.6
-
78
-
-
1542329143
-
Lymphatic density and metastatic spread in human malignant melanoma
-
Shields J.D., Borsetti M., Rigby H., Harper S.J., Mortimer P.S., Levick J.R., et al. Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer 2004, 90:693-700.
-
(2004)
Br J Cancer
, vol.90
, pp. 693-700
-
-
Shields, J.D.1
Borsetti, M.2
Rigby, H.3
Harper, S.J.4
Mortimer, P.S.5
Levick, J.R.6
-
79
-
-
33745077057
-
Immune responses in the draining lymph nodes against cancer: implications for immunotherapy
-
Shu S., Cochran A.J., Huang R.R., Morton D.L., Maecker H.T. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy. Cancer Metastasis Rev 2006, 25:233-242.
-
(2006)
Cancer Metastasis Rev
, vol.25
, pp. 233-242
-
-
Shu, S.1
Cochran, A.J.2
Huang, R.R.3
Morton, D.L.4
Maecker, H.T.5
-
80
-
-
84863480813
-
Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node
-
Ma M.W., Medicherla R.C., Qian M., Vega-Saenz de Miera E., Friedman E.B., Berman R.S., et al. Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node. Mod Pathol 2012, 25:1000-1010.
-
(2012)
Mod Pathol
, vol.25
, pp. 1000-1010
-
-
Ma, M.W.1
Medicherla, R.C.2
Qian, M.3
Vega-Saenz de Miera, E.4
Friedman, E.B.5
Berman, R.S.6
-
81
-
-
84873809917
-
Prognostic value of BRAF (V600) mutations in melanoma patients after resection of metastatic lymph nodes
-
Moreau S., Saiag P., Aegerter P., Bosset D., Longvert C., Helias-Rodzewicz Z., et al. Prognostic value of BRAF (V600) mutations in melanoma patients after resection of metastatic lymph nodes. Ann Surg Oncol 2012, 19:4314-4321.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 4314-4321
-
-
Moreau, S.1
Saiag, P.2
Aegerter, P.3
Bosset, D.4
Longvert, C.5
Helias-Rodzewicz, Z.6
-
82
-
-
84872595484
-
BRAF mutation, NRAS mutation, and the Absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma
-
Mann G.J., Pupo G.M., Campain A.E., Carter C.D., Schramm S.J., Pianova S., et al. BRAF mutation, NRAS mutation, and the Absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. J Invest Dermatol 2013, 133:509-517.
-
(2013)
J Invest Dermatol
, vol.133
, pp. 509-517
-
-
Mann, G.J.1
Pupo, G.M.2
Campain, A.E.3
Carter, C.D.4
Schramm, S.J.5
Pianova, S.6
|